Braeburn Pharmaceuticals
Edit

Braeburn Pharmaceuticals

https://www.braeburnpharmaceuticals.com/
Last activity: 25.06.2024
Probably Closed
Long-acting therapies for opioid use disorders.
Princeton, NJ
Mentions
9
Total raised: $110M

Investors 1

Funding Rounds 1

DateSeriesAmountInvestors
11.01.2018-$110MRA Capital...

Mentions in press and media 9

DateTitleDescription
25.06.2024New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanylNew publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl Tue, Jun 25, 2024 17:00 CET Report this content Lund, Sweden — 25 June 2024 — Camurus (NASD...
22.01.2018FDA slaps down Brae­burn on opi­oid ad­dic­tion drug, putting In­di­v­ior and Alk­er­mes in strong po­si­tionOne of the fron­trun­ners in the rush to get new opi­oid ad­dic­tion treat­ments to the mar­ket has just hit a road­block. Just days be­fore its PDU­FA date, Brae­burn Phar­ma­ceu­ti­cals got a com­plete re­sponse let­ter from the FDA in li...
12.01.2018Term Sheet — Friday, January 12CUDDLE PUDDLES Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop Last night, Axios reported that one of these parties was held at venture capitalist Steve Jurvetson’s home. The party fol...
11.01.2018Braeburn Pharmaceuticals Nabs $110M PRINCETON, N.J., Braeburn Pharmaceuticals, (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. >> Click here for more funding data on Braeburn ...
11.01.2018RA Capital Joins $110M Funding for Braeburn PharmaceuticalsBraeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap...
11.01.2018Rock Springs Capital Joins $110M Funding for Braeburn PharmaceuticalsBraeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap...
11.01.2018Braeburn Pharmaceuticals Completes $110M Mezzanine Round of FinancingBraeburn Pharmaceuticals, Inc., a Princeton, N.J.-based pharmaceutical company, completed a $110m mezzanine round of financing. The round was led by Wellington Capital Management with participation from new investors Avista Capital Partners...
10.01.2018Braeburn Announces Completion of $110 Million FinancingPrinceton, N.J.— January 10, 2018 — Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating...
04.01.2017Term Sheet — Wednesday, January 4DELL-EMC, NYC EXITS, HYPEMOBILES Hello from Las Vegas, where I’m riding in cars with robots and hunting down the most ridiculous “smart” items CES has to offer. (Current front-runners: a smart mattress and a smart hairbrush.) Paid Content S...

Reviews 0

Sign up to leave a review

Sign up Log In